USPTO serial 87566059
Serial No. 87566059
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 6, 2018
- Examiner
- CORNWELL, ANDREA B
- Law office
- TMO LAW OFFICE 115
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with Serial No. 87566059?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Innovative Cellular Therapeutics CO., LTD.
Shanghai, CN
Other trademarks owned by Innovative Cellular Therapeutics CO., LTD.
Innovative Cellular Therapeutics CO., LTD.
Shanghai, CN
Other trademarks owned by Innovative Cellular Therapeutics CO., LTD.
Innovative Cellular Therapeutics CO., LTD.
Shanghai, CN
Other trademarks owned by Innovative Cellular Therapeutics CO., LTD.
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LIMITED
George Town, KY
Other trademarks owned by INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LIMITED
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rhett V. Barney
Rhett V. Barney Lee & Hayes, PC601 W. Riverside Ave. Suite 1400Spokane, WA 99201UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields | ACTIVE | Feb 10, 2017 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Innovative Cellular Therapeutics CO., LTD.
- Other trademarks owned by Innovative Cellular Therapeutics CO., LTD.
- Other trademarks owned by Innovative Cellular Therapeutics CO., LTD.
- Other trademarks owned by INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LIMITED
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 14, 2023 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Nov 14, 2023 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Nov 14, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 15, 2023 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Mar 6, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jun 23, 2021 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 6, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 19, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 19, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 29, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 9, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 6, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 19, 2017 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 18, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 15, 2017 | NWAP | NEW APPLICATION ENTERED | — |